2-Chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide

Catalog No.: 
ACNVXO638
CAS No.: 
565166-64-5
Molecular Formula: 
C19H17ClN2OS
Molecular Weight: 
356.88
2-Chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$72.00InquiryInquiry
100mg95%$104.00InquiryInquiry
250mg95%$136.00InquiryInquiry
1g95%$348.00InquiryInquiry
5g95%$977.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide
IUPAC Name2-chloro-N-(4-(4-ethylphenyl)thiazol-2-yl)-2-phenylacetamide
MDL No.MFCD03966887
Molecular FormulaC19H17ClN2OS
Molecular Weight356.88
SMILESO=C(NC1=NC(C2=CC=C(CC)C=C2)=CS1)C(Cl)C3=CC=CC=C3
InChI KeyGOJIUMVBUCJFTR-UHFFFAOYSA-N
Synonym2-chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide
CAS No.565166-64-5

Synthetic Route by SureRoute

1. ACNVXO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWGSJ026 route compound structure diagram
    ACWGSJ0262912-62-1In Stock
  4. Then
  5. ACNVXO638 route product structure diagram
    ACNVXO638565166-64-5
Inquiry

2. ACNVXO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGCPQ065 route compound structure diagram
    ACGCPQ0654755-72-0In Stock
  4. Then
  5. ACNVXO638 route product structure diagram
    ACNVXO638565166-64-5
Inquiry

3. ACNVXO638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWCA690 route compound structure diagram
    ACYWCA6902632-14-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNVXO638 route product structure diagram
    ACNVXO638565166-64-5
Inquiry

Comments (0)